Work from our group demonstrated that tumor-derived EVs (tdEVs) expressed altered levels of reactive oxygen species (ROS), P53 pathways, inflammatory/cytokines, oncogenes, and tumor suppressor genes in the EV nanosatellites after tumor resection [26]. The gene discussed is TP53; the disease is neoplasm.